These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1082719)

  • 1. Necrotic myelopathy (myelomalacia) in rats with allergic encephalomyelitis treated with tilorone.
    Levine S; Sowinski R
    Am J Pathol; 1976 Feb; 82(2):381-92. PubMed ID: 1082719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental allergic encephalomyelitis by tilorone: cell transfer and interferon studies.
    Levine S; Sowinski R; Abreu SL
    Immunopharmacology; 1983 Jun; 6(1):23-30. PubMed ID: 6223898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats treated with fucoidan.
    Kim H; Moon C; Park EJ; Jee Y; Ahn M; Wie MB; Shin T
    Phytother Res; 2010 Mar; 24(3):399-403. PubMed ID: 19655293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
    Li XB; Schluesener HJ
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
    Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S
    Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence of tissue responses in the early stages of experimental allergic encephalomyelitis (EAE): immunohistochemical, light microscopic, and ultrastructural observations in the spinal cord.
    D'Amelio FE; Smith ME; Eng LF
    Glia; 1990; 3(4):229-40. PubMed ID: 2144503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis.
    Swierkosz JE; Swanborg RH
    J Immunol; 1975 Sep; 115(3):631-3. PubMed ID: 50370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats.
    Chelmicka-Schorr E; Wiegmann K; Wollmann R; Arnason BG; Kim DH
    J Autoimmun; 1998 Aug; 11(4):329-34. PubMed ID: 9776710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP; Piddlesden S; Morgan BP; Reynolds R
    Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1.
    Kang JC; Ahn M; Kim YS; Moon C; Lee Y; Wie MB; Lee YJ; Shin T
    J Vet Sci; 2001 Aug; 2(2):85-9. PubMed ID: 14614276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties.
    Whitacre CC; Paterson PY
    J Immunol; 1980 Apr; 124(4):1784-8. PubMed ID: 6965962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat.
    Stohl W; Gonatas NK
    J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative assay for experimental allergic encephalomyelitis in the rat based on permeability of spinal cords to 125I-human gamma-globulin.
    Stohl W; Kaplan MS; Gonatas NK
    J Immunol; 1979 Mar; 122(3):920-5. PubMed ID: 87421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
    Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
    Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the hyperacute form of experimental allergic encephalomyelitis by drugs.
    Levine S; Sowinski R
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):309-18. PubMed ID: 603323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prazosin treatment during the effector stage of disease suppresses experimental autoimmune encephalomyelitis in the Lewis rat.
    Brosnan CF; Sacks HJ; Goldschmidt RC; Goldmuntz EA; Norton WT
    J Immunol; 1986 Dec; 137(11):3451-6. PubMed ID: 3491136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased phosphorylation of caveolin-1 in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis.
    Kim H; Ahn M; Lee J; Moon C; Matsumoto Y; Koh CS; Shin T
    Neurosci Lett; 2006 Jul; 402(1-2):76-80. PubMed ID: 16678345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte targeting of the brain in adoptive transfer cryolesion-EAE.
    Lake J; Weller RO; Phillips MJ; Needham M
    J Pathol; 1999 Jan; 187(2):259-65. PubMed ID: 10365103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enkephalins and autoimmunity: differential effect of methionine-enkephalin on experimental allergic encephalomyelitis in Wistar and Lewis rats.
    Janković BD; Marić D
    J Neurosci Res; 1987; 18(1):88-94. PubMed ID: 3500326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.